Xinyu Tang

ORCID: 0000-0002-4567-4012 · 8 papers in corpus
other 2026
iScience ·doi:10.1016/j.isci.2026.117153

Endometriosis has limited treatment options, prompting the search for data-driven therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline and identified several drug candidates. Fenoprofen, our top…

other 2026
bioRxiv : the preprint server for biology ·doi:10.64898/2026.07.17.739227

Transcriptome-based drug repurposing can accelerate therapeutic discovery, but is limited by fragmented resources, inconsistent quality control, and reliance on single perturbation databases. We developed CDRPipe (Computational Drug Repurpo…

2026
Research square ·doi:10.21203/rs.3.rs-10606217/v1

BACKGROUND: Transcriptome-based drug repurposing can accelerate therapeutic discovery, but is limited by fragmented resources, inconsistent quality control, and reliance on single perturbation databases. METHODS: We developed CDRPipe (Comp…

lab-animal 2026
bioRxiv : the preprint server for biology ·doi:10.64898/2026.09.27.754752

BACKGROUND: Endometriosis is an estrogen-driven, inflammatory disorder affecting ~10% of menstruators, causing severe pain. Current treatments that reduce estrogen or inflammation have inconsistent efficacy and poor tolerability. Therapies …

lab-animal 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.05.28.656743

INTRODUCTION AND METHODS: Endometriosis has limited treatment options, prompting the search for novel therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline to analyze public bulk transcriptomic d…

other 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.07.21.666016

Endometriosis is a chronic, estrogen-dependent condition affecting over 190 million women globally, characterized by the ectopic presence of endometrial-like tissue that leads to inflammation, pain, and infertility. Despite its prevalence, …

observational 2016
Annals of human genetics ·doi:10.1111/ahg.12139

Congenital heart defects (CHDs) develop through a complex interplay between genetic variants, epigenetic modifications, and maternal environmental exposures. Genetic studies of CHDs have commonly tested single genetic variants for associati…

observational 2014
Human genetics ·doi:10.1007/s00439-014-1453-1

The development of congenital heart defects (CHDs) involves a complex interplay between genetic variants, epigenetic variants, and environmental exposures. Previous studies have suggested that susceptibility to CHDs is associated with mater…